These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1563484)

  • 1. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype.
    Campbell JH; Rennick RE; Kalevitch SG; Campbell GR
    Exp Cell Res; 1992 May; 200(1):156-67. PubMed ID: 1563484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The macrophage as an initiator of atherosclerosis.
    Campbell JH; Campbell GR
    Clin Exp Pharmacol Physiol; 1991 Feb; 18(2):81-4. PubMed ID: 2022080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocytes affect smooth muscle cell phenotype and proliferation.
    Rolfe BE; Campbell JH; Smith NJ; Cheong MW; Campbell GR
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1204-10. PubMed ID: 7627715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subendothelial extracellular-matrix heparan sulfate proteoglycan-degrading activity of human monocyte macrophages.
    Shimada K; Ozawa T
    Heart Vessels; 1987; 3(4):175-81. PubMed ID: 2969381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein.
    Kaplan M; Aviram M
    Atherosclerosis; 2000 Mar; 149(1):5-17. PubMed ID: 10704609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and turnover of cell surface-associated heparan sulfate proteoglycan and chondroitin sulfate proteoglycan in normal and cholesterol-enriched macrophages.
    Owens RT; Wagner WD
    Arterioscler Thromb; 1991; 11(6):1752-8. PubMed ID: 1931877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation.
    Benitz WE; Kelley RT; Anderson CM; Lorant DE; Bernfield M
    Am J Respir Cell Mol Biol; 1990 Jan; 2(1):13-24. PubMed ID: 2137707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
    Klein DJ; Oegema TR; Brown DM
    Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation.
    Cisar LA; Hoogewerf AJ; Cupp M; Rapport CA; Bensadoun A
    J Biol Chem; 1989 Jan; 264(3):1767-74. PubMed ID: 2521485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization of proteoglycans synthesized by human glomerular epithelial cells in culture.
    Klein DJ; Oegema TR; Fredeen TS; van der Woude F; Kim Y; Brown DM
    Arch Biochem Biophys; 1990 Mar; 277(2):389-401. PubMed ID: 2106832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
    Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
    J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
    Kinsella MG; Irvin C; Reidy MA; Wight TN
    Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors increase pericellular proteoglycans independently of their mitogenic effects on A10 rat vascular smooth muscle cells.
    Emoto N; Onose H; Yamada H; Minami S; Tsushima T; Wakabayashi I
    Int J Biochem Cell Biol; 1998 Jan; 30(1):47-54. PubMed ID: 9597753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.
    Edwards IJ; Wagner WD; Owens RT
    Am J Pathol; 1990 Mar; 136(3):609-21. PubMed ID: 2316626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate proteoglycan and heparan sulfate proteoglycan production by cultured pigeon peritoneal macrophages.
    Owens RT; Wagner WD
    J Leukoc Biol; 1992 Jun; 51(6):626-33. PubMed ID: 1613397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human glomerular epithelial cell proteoglycans.
    Thomas GJ; Jenner L; Mason RM; Davies M
    Arch Biochem Biophys; 1990 Apr; 278(1):11-20. PubMed ID: 2181935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface heparan sulfate proteoglycan and chondroitin sulfate proteoglycan of arterial smooth muscle cells.
    Edwards IJ; Wagner WD
    Am J Pathol; 1992 Jan; 140(1):193-205. PubMed ID: 1731524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulphate-degrading endoglycosidase in liver plasma membranes.
    Gallagher JT; Walker A; Lyon M; Evans WH
    Biochem J; 1988 Mar; 250(3):719-26. PubMed ID: 3390139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.